Membrane-Bound Hyaluronidase in Breast Cancer Progression

2001 ◽  
Author(s):  
Lurong Zhang
Keyword(s):  
Breast Cancer ◽  
Cancer Progression ◽  
Breast Cancer Progression ◽  
Membrane Bound

scholarly journals Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression

2009 ◽  
Vol 30 (3) ◽  
pp. 397-407 ◽  
Author(s):  
Viktoriya Nikolova ◽  
Chuay-Yeng Koo ◽  
Sherif Abdelaziz Ibrahim ◽  
Zihua Wang ◽  
Dorothe Spillmann ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Progression ◽  
Breast Cancer Progression ◽  
Membrane Bound

scholarly journals Advances of Exosomal miRNAs in Breast Cancer Progression and Diagnosis

Diagnostics ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 2151
Author(s):  
Wenwen Chen ◽  
Zhongyu Li ◽  
Pengwei Deng ◽  
Zhengnan Li ◽  
Yuhai Xu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Diagnosis ◽  
Cancer Progression ◽  
Breast Cancer Diagnosis ◽  
Breast Cancer Progression ◽  
Breast Tumorigenesis ◽  
Exosomal Mirnas ◽  
The Status ◽  
Tumorigenesis And Progression ◽  
Membrane Bound

Breast cancer is one of the most commonly diagnosed malignancies and the leading cause of cancer death in women worldwide. Although many factors associated with breast cancer have been identified, the definite etiology of breast cancer is still unclear. In addition, early diagnosis of breast cancer remains challenging. Exosomes are membrane-bound nanovesicles secreted by most types of cells and contain a series of biologically important molecules, such as lipids, proteins, and miRNAs, etc. Emerging evidence shows that exosomes can affect the status of cells by transmitting substances and messages among cells and are involved in various physiological and pathological processes. In breast cancer, exosomes play a significant role in breast tumorigenesis and progression through transfer miRNAs which can be potential biomarkers for early diagnosis of breast cancer. This review discusses the potential utility of exosomal miRNAs in breast cancer progression such as tumorigenesis, metastasis, immune regulation and drug resistance, and further in breast cancer diagnosis.

Beta haemoglobin (hbb) is a novel marker of breast cancer progression

2014 ◽  
Author(s):  
Mattia Capulli ◽  
Adriano Angelucci ◽  
Anna Teti ◽  
Patrizia Sanita ◽  
Luca Ventura ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Progression ◽  
Breast Cancer Progression
Sign in / Sign up

Export Citation Format

Share Document